Amyris, a synthetic biotechnology company specializing in cosmetics, flavors, and fragrances, has successfully scaled up production of Cannabigerol (CBG), a non-psychoactive cannabinoid. Often referred to
Amyris, a synthetic biotechnology company specializing in cosmetics, flavors, and fragrances, has successfully scaled up production of Cannabigerol (CBG), a non-psychoactive cannabinoid. Often referred to as “the stemcell of cannabinoids,” CBG is the precursor from which all other cannabinoids are synthesized and is purported to…
MJBI is dedicated to providing a sharp, substantive, and reliable source of industry intel for cannabis brands and retailers. We accelerate sustainable growth by fostering enlightening peer-to-peer collaboration.